Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis
about
Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)Origin and molecular pathogenesis of ovarian high-grade serous carcinomaSociety of Gynecologic Oncology recommendations for the prevention of ovarian cancerRecent concepts of ovarian carcinogenesis: type I and type IImiR-200c Regulation of Metastases in Ovarian Cancer: Potential Role in Epithelial and Mesenchymal TransitionSerous tubal intraepithelial carcinomas associated with high-grade serous ovarian carcinomas: a systematic review.Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the EvidenceTP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions.Telomere length and mortality following a diagnosis of ovarian cancerMolecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.Comparison of candidate serologic markers for type I and type II ovarian cancerPrecursors of ovarian cancer in the fallopian tube: serous tubal intraepithelial carcinoma--an update.Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas.Microenvironment and pathogenesis of epithelial ovarian cancerLongitudinal change in telomere length and the chronic stress response in a randomized pilot biobehavioral clinical study: implications for cancer preventionTelomere length and genetic variation in telomere maintenance genes in relation to ovarian cancer riskOvarian Cancer Is an Imported Disease: Fact or Fiction?The diagnostic and biological implications of laminin expression in serous tubal intraepithelial carcinoma.Telomere length in different histologic types of ovarian carcinoma with emphasis on clear cell carcinoma.YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells.Ki-67 labeling index as an adjunct in the diagnosis of serous tubal intraepithelial carcinoma.ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas.Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling.BRCA and Early Events in the Development of Serous Ovarian Cancer.Advances in serous tubal intraepithelial carcinoma: correlation with high grade serous carcinoma and ovarian carcinogenesis.Early preinvasive lesions in ovarian cancer.Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.Assignment of primary site in high-grade serous tubal, ovarian and peritoneal carcinoma: a proposal.High-grade serous carcinoma of tubo-ovarian origin: recent developments.Prediagnosis Leukocyte Telomere Length and Risk of Ovarian Cancer.New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal dissemination.The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded.Serous tubal intraepithelial carcinoma (STIC) - clinical impact and management.Low-Stage High-Grade Serous Ovarian Carcinomas: Support for an Extraovarian Origin.The conceptual advances of carcinogenic sequence model in high-grade serous ovarian cancer.Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma.Telomere shortening distinguishes inverted urothelial neoplasms.Frequent CCNE1 amplification in endometrial intraepithelial carcinoma and uterine serous carcinoma.Correlation of telomere length to malignancy potential in non-melanoma skin cancers.Extrauterine high-grade serous carcinomas with bilateral adnexal involvement as the only two disease sites are clonal based on tp53 sequencing results: implications for biology, classification, and staging.
P2860
Q26852127-0EA1D93C-0A5A-4B7E-8349-68F9CC6D6194Q26852698-450DE982-7BA5-4781-89CB-1A0C9EE00F14Q27009306-061369DD-D039-47B5-87C6-61AEBDFDA7B7Q27009487-2F5A2E1A-0880-485B-B8C7-D11E0F8C4DA1Q28071987-42945A29-EEEE-4D01-9BAC-FA8FB0644429Q30235845-5515F97A-F901-44B3-869B-E7A569241165Q30250107-378E92DA-591F-46FB-A7B7-40C9D893D974Q34223292-AFDC2D87-7A73-416B-BFE0-1268C9237D0EQ34459050-C768568E-501B-4B45-B4FE-02AAC24B7D18Q35140600-7FF2DE9E-570D-4ACD-B0DC-C4C9590A8DA4Q35154077-0437EC5B-BD36-49FB-8C0D-C7AD67319FD0Q35155614-F04F7CAB-D375-4A20-B40E-140319578788Q35209384-C64DC47E-140A-4207-A284-E8899663EFFDQ35419057-D4FA980C-71CE-46F8-93AE-31244BB54CD5Q35776897-752E7E85-D29D-40B2-A933-7F20A6BCAA87Q35815552-39B01BD9-5106-43F9-92BE-793A10C8B82BQ35878320-32186F94-DEA4-4BF9-95C7-1FBADF5DFE67Q36405881-69B263C3-A5AF-4D14-B409-6653E0FF5DDBQ36608043-30313FA0-29FC-4B4B-B8A7-5FE20CD8D7F0Q36685324-457EB79B-D27E-49B0-976A-4E01C18274BEQ37023858-589770E7-67C7-4085-A4FB-F7A66C881CB8Q37225222-FB6BF5E4-A340-44B6-907A-ADBA7D72231FQ37395388-CD47EF0C-38A1-4810-A1EB-63310511F8A8Q37513137-18F289BB-8F0B-48D0-909D-E2877664CC37Q37676705-81C01C79-CA71-41EC-96EA-E9A30828F884Q37719090-0C8C9F24-9B8F-45B0-8CC1-1C45FC9B36E1Q38067435-20439DEF-FE3C-4275-83D1-6CF91D9E6733Q38198705-8EBD8484-634B-4533-AC9F-F69874E90F83Q38687061-836F5A10-BC19-44BC-B0C7-71E088C62936Q38756382-3F861761-235C-4AE9-A2E6-9EE582D673F6Q38777812-385187BD-FB5F-4ECD-96DC-34BE2E106684Q38787667-C078D77B-71C6-4127-9370-E006B5CB1CA9Q38978839-633D4656-3C06-4F6A-9583-6A7A8904FFF1Q41167815-989F5E3B-E677-4299-A1E4-44BE36CF4142Q41294690-6CF7CFB2-786B-4249-9BCC-75CBC771B581Q42379619-0D6F64E0-F575-4404-B5E7-B601F86DCCD2Q44892650-C89B0C59-ED98-40A3-949A-2681EADFF5C1Q45228114-01C9FF7F-DFDE-4776-9992-94946E97AB06Q47131091-9DC6EDFA-F410-439E-B9C6-70838AAC55CBQ47610274-B4AABD5F-3625-461E-8464-CC99972F68ED
P2860
Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Shortened telomeres in serous ...... gh-grade serous carcinogenesis
@ast
Shortened telomeres in serous ...... gh-grade serous carcinogenesis
@en
type
label
Shortened telomeres in serous ...... gh-grade serous carcinogenesis
@ast
Shortened telomeres in serous ...... gh-grade serous carcinogenesis
@en
prefLabel
Shortened telomeres in serous ...... gh-grade serous carcinogenesis
@ast
Shortened telomeres in serous ...... gh-grade serous carcinogenesis
@en
P2093
P2860
P1476
Shortened telomeres in serous ...... gh-grade serous carcinogenesis
@en
P2093
Alan Meeker
Ann Smith Sehdev
Elisabetta Kuhn
Ie-Ming Shih
Robert J Kurman
Tian-Li Wang
P2860
P304
P356
10.1097/PAS.0B013E3181DCEDE7
P407
P577
2010-06-01T00:00:00Z